FluGen
Latest round
- Series A
Last raised
- Aug 2015
Total raised
- $9.4M
Investors
- 4
About FluGen
FluGen, Inc.Founded in 2007 and headquartered in Madison, US, FluGen, Inc. specializes in flu vaccine development, notably the M2SR vaccine platform.50 mn.FluGen, Inc. primarily offers the M2SR Vaccine Platform, designed for the prevention of influenza and respiratory diseases. The flagship product, M2SR, is an intranasal, supra-seasonal flu vaccine that promotes a comprehensive immune response. It effectively addresses critical unmet needs in flu prevention, providing consistent efficacy against annual virus drift and shedding.FluGen, Inc. generates revenue primarily through partnerships and collaborations with healthcare organizations and institutions involved in vaccine distribution and public health initiatives. The business model focuses on B2B transactions, facilitating the deployment of the M2SR vaccine in clinical settings, which may include arrangements with governmental health agencies and private healthcare providers.FluGen, Inc. The company aims to expand its presence in North America and Europe by enhancing distribution networks and forming additional partnerships with health agencies by the end of 2023. Continued focus on clinical trial advancements will also be critical to its growth strategy, positioning the M2SR vaccine as a key solution against influenza and respiratory diseases.
Who invested in FluGen
4 investors across 1 round
See all investors in FluGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 10, 2015
Amount
$9.4M
Investors
Questions about FluGen
Who invested in FluGen?
FluGen has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FluGen raised?
FluGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did FluGen last raise money?
FluGen's most recent round on record is a Series A, in Aug 2015.
What does FluGen do?
FluGen is a pharmaceuticals company.
Where is FluGen headquartered?
FluGen is headquartered in Madison, US.
Which VCs invest in companies like FluGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at FluGen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like FluGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.